Being Gram-negative bacteria, most Pseudomonas spp. are naturally resistant to penicillin and the majority of related beta-lactam antibiotics, but a number are sensitive to piperacillin, imipenem, ticarcillin, or ciprofloxacin. Aminoglycosides such as tobramycin, gentamicin, and amikacin are other choices for therapy.This ability to thrive in harsh conditions is a result of their hardy cell walls that contain porins. Pseudomonas aeruginosa is increasingly recognized as an emerging opportunistic pathogen of clinical relevance. One of its most worrying characteristics is its low antibiotic susceptibility.This low susceptibility is attributable to a concerted action of multidrug efflux pumps with chromosomally encoded antibiotic resistance genes.Pseudomonas aeruginosa is a major cause of nosocomial infections. P. aeruginosa continue to be the commonest cause of hospital infections. The diversity of clinics and the regional variations in antibiotic protocols result in the different resistance profiles.Keeping these all parameters this book will help in understanding extended spectrum beta-lactamase by Pseudomonas spp. isolated from pus, sputum, CSF, blood, urine, and other body fluid.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Being Gram-negative bacteria, most Pseudomonas spp. are naturally resistant to penicillin and the majority of related beta-lactam antibiotics, but a number are sensitive to piperacillin, imipenem, ticarcillin, or ciprofloxacin. Aminoglycosides such as tobramycin, gentamicin, and amikacin are other choices for therapy.This ability to thrive in harsh conditions is a result of their hardy cell walls that contain porins. Pseudomonas aeruginosa is increasingly recognized as an emerging opportunistic pathogen of clinical relevance. One of its most worrying characteristics is its low antibiotic susceptibility.This low susceptibility is attributable to a concerted action of multidrug efflux pumps with chromosomally encoded antibiotic resistance genes.Pseudomonas aeruginosa is a major cause of nosocomial infections. P. aeruginosa continue to be the commonest cause of hospital infections. The diversity of clinics and the regional variations in antibiotic protocols result in the different resistance profiles.Keeping these all parameters this book will help in understanding extended spectrum beta-lactamase by Pseudomonas spp. isolated from pus, sputum, CSF, blood, urine, and other body fluid.
Ashis Kothari did his graduation in genetic engineering & MSc Medical Microbiology from M.M.I.M.S.R, Ambala & research project in Canada. Author Rahul Prabhas has done his BSc.(Hons) Microbiology from University of Delhi and MSc.Medical Microbiology from M.M. Institute of Medical Science And Research,Ambala. Arun Kumar did his MSc from IIT, Mumbai.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Being Gram-negative bacteria, most Pseudomonas spp. are naturally resistant to penicillin and the majority of related beta-lactam antibiotics, but a number are sensitive to piperacillin, imipenem, ticarcillin, or ciprofloxacin. Aminoglycosides such as tobramycin, gentamicin, and amikacin are other choices for therapy.This ability to thrive in harsh conditions is a result of their hardy cell walls that contain porins. Pseudomonas aeruginosa is increasingly recognized as an emerging opportunistic pathogen of clinical relevance. One of its most worrying characteristics is its low antibiotic susceptibility.This low susceptibility is attributable to a concerted action of multidrug efflux pumps with chromosomally encoded antibiotic resistance genes.Pseudomonas aeruginosa is a major cause of nosocomial infections. P. aeruginosa continue to be the commonest cause of hospital infections. The diversity of clinics and the regional variations in antibiotic protocols result in the different resistance profiles.Keeping these all parameters this book will help in understanding extended spectrum beta-lactamase by Pseudomonas spp. isolated from pus, sputum, CSF, blood, urine, and other body fluid. 76 pp. Englisch. N° de réf. du vendeur 9786202012133
Quantité disponible : 2 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 76 pages. 8.66x5.91x0.18 inches. In Stock. N° de réf. du vendeur zk6202012137
Quantité disponible : 1 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Kothari AshishAshis Kothari did his graduation in genetic engineering & MSc Medical Microbiology from M.M.I.M.S.R, Ambala & research project in Canada. Author Rahul Prabhas has done his BSc.(Hons) Microbiology from University of Delh. N° de réf. du vendeur 160565534
Quantité disponible : Plus de 20 disponibles
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Being Gram-negative bacteria, most Pseudomonas spp. are naturally resistant to penicillin and the majority of related beta-lactam antibiotics, but a number are sensitive to piperacillin, imipenem, ticarcillin, or ciprofloxacin. Aminoglycosides such as tobramycin, gentamicin, and amikacin are other choices for therapy.This ability to thrive in harsh conditions is a result of their hardy cell walls that contain porins. Pseudomonas aeruginosa is increasingly recognized as an emerging opportunistic pathogen of clinical relevance. One of its most worrying characteristics is its low antibiotic susceptibility.This low susceptibility is attributable to a concerted action of multidrug efflux pumps with chromosomally encoded antibiotic resistance genes.Pseudomonas aeruginosa is a major cause of nosocomial infections. P. aeruginosa continue to be the commonest cause of hospital infections. The diversity of clinics and the regional variations in antibiotic protocols result in the different resistance profiles.Keeping these all parameters this book will help in understanding extended spectrum beta-lactamase by Pseudomonas spp. isolated from pus, sputum, CSF, blood, urine, and other body fluid.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 76 pp. Englisch. N° de réf. du vendeur 9786202012133
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Being Gram-negative bacteria, most Pseudomonas spp. are naturally resistant to penicillin and the majority of related beta-lactam antibiotics, but a number are sensitive to piperacillin, imipenem, ticarcillin, or ciprofloxacin. Aminoglycosides such as tobramycin, gentamicin, and amikacin are other choices for therapy.This ability to thrive in harsh conditions is a result of their hardy cell walls that contain porins. Pseudomonas aeruginosa is increasingly recognized as an emerging opportunistic pathogen of clinical relevance. One of its most worrying characteristics is its low antibiotic susceptibility.This low susceptibility is attributable to a concerted action of multidrug efflux pumps with chromosomally encoded antibiotic resistance genes.Pseudomonas aeruginosa is a major cause of nosocomial infections. P. aeruginosa continue to be the commonest cause of hospital infections. The diversity of clinics and the regional variations in antibiotic protocols result in the different resistance profiles.Keeping these all parameters this book will help in understanding extended spectrum beta-lactamase by Pseudomonas spp. isolated from pus, sputum, CSF, blood, urine, and other body fluid. N° de réf. du vendeur 9786202012133
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Understanding Extended Spectrum Beta-Lactamase(ESBL)Among Pseudomonas | A Rational Way To Prescribe Antibiotic before treatment | Ashish Kothari (u. a.) | Taschenbuch | 76 S. | Englisch | 2017 | LAP LAMBERT Academic Publishing | EAN 9786202012133 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 109629825
Quantité disponible : 5 disponible(s)